Clinical trial
The Effect of Correction of Metabolic Acidosis in CKD on Intrarenal RAS Activity
NCT02896309 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Correction of Metabolic Acidosis in CKD on Intrarenal RAS Activity
- Lead sponsor
- Erasmus Medical Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 2016
- Completion date
- December 27, 2018
- Enrollment
- 45 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic kidney disease